Delivery Systems for Biologics

Overview


Significant research and development interest exists in developing less-invasive or non-invasive routes for the systemic delivery of biologics, including subcutaneous, transdermal, oral, inhalation, nasal and buccal routes. This webinar will look at the current status, latest updates and future prospects for innovative delivery of peptides, proteins and other biologics.

Speakers

Roy Eldor, M.D., Ph.D.
Roy Eldor, M.D., Ph.D.
Chief Medical Advisor
Oramed Pharmaceuticals
Mark Heinnickel
Mark Heinnickel
Principal Scientist
Lumen Bioscience
Jane Byrne
Jane Byrne
Senior Editor
BioPharma-Reporter

View webinar


We are sorry, the video is not yet ready.Please come back soon.

Share Event